Acquisition by Gabay Avraham of 140040 shares of Oramed Pharmaceuticals subject to Rule 16b-3

ORMP Stock  USD 2.51  0.01  0.40%   
Slightly above 59% of Oramed Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Oramed Pharmaceuticals stock suggests that many investors are alarmed at this time. Oramed Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Oramed Pharmaceuticals. Many technical investors use Oramed Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Oramed Pharmaceuticals Officer: Chief Financial Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Oramed insider trading alert for acquisition of common stock by Gabay Avraham, Officer: Chief Financial Officer, on 21st of June 2024. This event was filed by Oramed Pharmaceuticals with SEC on 2024-06-21. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Oramed Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Oramed Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Oramed Pharmaceuticals Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Oramed Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Oramed Pharmaceuticals Fundamental Analysis

We analyze Oramed Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oramed Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oramed Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Oramed Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Oramed Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oramed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Oramed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Oramed Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Oramed Pharmaceuticals Related Equities

XFORX4 Pharmaceuticals   26.42   
0%
100.0%
ELEVElevation Oncology   15.38   
0%
58.0%
INZYInozyme Pharma   9.56   
0%
36.0%
ENVBEnveric Biosciences   9.09   
0%
34.0%
MCRBSeres Therapeutics   8.14   
0%
30.0%
TERNTerns Pharmaceuticals   5.17   
0%
19.0%
PLXProtalix Biotherapeutics   3.98   
0%
15.0%
HEPAHepion Pharmaceuticals   3.28   
0%
12.0%
MREOMereo BioPharma   1.58   
0%
5.0%
ALDXAldeyra   1.15   
0%
4.0%
ZURAZura Bio   0.72   
0%
2.0%
CKPTCheckpoint Therapeutics   1.01   
3.0%
0%
LPTXLeap Therapeutics   1.25   
4.0%
0%
LXRXLexicon Pharmaceuticals   1.35   
5.0%
0%
CRVSCorvus Pharmaceuticals   1.60   
6.0%
0%
OCEAOcean Biomedical   2.86   
10.0%
0%
IBRXImmunitybio   3.33   
12.0%
0%
BLRXBioLineRx   4.00   
15.0%
0%
CYTOAltamira Therapeutics   6.12   
23.0%
0%
ARDXArdelyx   7.87   
29.0%
0%
IMMXImmix Biopharma   13.78   
52.0%
0%
PALIPalisade Bio   20.88   
79.0%
0%

Additional Tools for Oramed Stock Analysis

When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.